![]() BIDDING ADIEU: David Kessler, who headed FDA for more than six years, says he is pleased with his record. |
While FDA officials claim that Kessler's departure will not affect the agency's plans to go ahead ...
BIDDING ADIEU: David Kessler, who headed FDA for more than six years, says he is pleased with his record. When David Kessler, the commissioner of the federal Food and Drug Administration (FDA), announced his resignation in late November, many people were surprised. The controversial FDA head was in the middle of waging war against the United States tobacco industry when he decided to step down after more than six years in the job. His supporters, including public health advocates, contend tha
![]() BIDDING ADIEU: David Kessler, who headed FDA for more than six years, says he is pleased with his record. |
While FDA officials claim that Kessler's departure will not affect the agency's plans to go ahead ...


When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.
View this Issue
In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.


In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.

In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.


Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy research.


Chief Business Officer Dr. Rob Burgess Shares How Sino Biological Is Empowering Global Biomedical Research Through Precision, Quality, and Innovation on an Exclusive Segment on Fox Business Network airing on February 1, 2026 at 4:30pm EST

Sino Biological, Inc. has announced the accelerated availability and development of critical research tools to support the global scientific community in combating NiV.

Collaboration will bring next generation orchestration and modular automation to scientists worldwide

The ranking places Refeyn among a cohort of high-growth UK technology firms spanning sectors including the life sciences, energy and sustainability, telecommunications, and digital technology.